National Health Investors (NYSE:NHI) Stock: Insider D. Eric Mendelsohn Buys 1,500 Shares

National Health Investors logo with Real Estate background
Image from MarketBeat Media, LLC.

Key Points

  • CEO D. Eric Mendelsohn bought 1,500 shares at an average price of $60.53, spending $90,795. His stake increased 1.13% to 134,816 shares.
  • National Health Investors declared a quarterly dividend of $0.92 per share, equivalent to $3.68 annually and a 6.1% yield at the article’s stated share price.
  • Analysts’ consensus rating was Moderate Buy, with an average price target of $79.11; Wells Fargo lowered its target to $65 while keeping an equal-weight rating.
  • MarketBeat previews the top five stocks to own by December 1st.

National Health Investors, Inc. (NYSE:NHI - Get Free Report) CEO D. Eric Mendelsohn acquired 1,500 shares of National Health Investors stock in a transaction that occurred on Tuesday, November 17th. The shares were purchased at an average price of $60.53 per share, with a total value of $90,795.00. Following the purchase, the chief executive officer owned 134,816 shares in the company, valued at $8,160,412.48. This represents a 1.13% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

National Health Investors Trading Down 1.0%

NYSE:NHI opened at $60.15 on Wednesday. National Health Investors, Inc. has a 52 week low of $59.05 and a 52 week high of $91.38. The firm has a 50 day moving average of $66.88 and a 200 day moving average of $75.66. The company has a quick ratio of 13.59, a current ratio of 13.59 and a debt-to-equity ratio of 0.50. The stock has a market capitalization of $2.95 billion, a price-to-earnings ratio of 4.22, a PEG ratio of 3.91 and a beta of 0.51.

National Health Investors (NYSE:NHI - Get Free Report) last announced its earnings results on Monday, November 9th. The real estate investment trust reported $11.47 earnings per share for the quarter, beating the consensus estimate of $1.18 by $10.29. National Health Investors had a net margin of 152.82% and a return on equity of 41.41%. The company had revenue of $113.48 million during the quarter, compared to the consensus estimate of $68.53 million. As a group, sell-side analysts anticipate that National Health Investors, Inc. will post 4.72 earnings per share for the current fiscal year.

National Health Investors Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 29th. Stockholders of record on Thursday, December 31st will be issued a dividend of $0.92 per share. This represents a $3.68 annualized dividend and a dividend yield of 6.1%. The ex-dividend date is Thursday, December 31st. National Health Investors's dividend payout ratio is currently 26.40%.

Institutional Investors Weigh In On National Health Investors

A number of large investors have recently made changes to their positions in NHI. BlackRock Inc. purchased a new stake in shares of National Health Investors in the second quarter valued at approximately $665,997,000. Bank of New York Mellon Corp purchased a new position in National Health Investors during the second quarter valued at $122,509,000. Bank of America Corp DE acquired a new stake in shares of National Health Investors in the second quarter valued at about $77,738,000. Legal & General Group Plc acquired a new stake in shares of National Health Investors in the second quarter valued at about $21,745,000. Finally, Sumitomo Mitsui Trust Group Inc. grew its position in shares of National Health Investors by 374.8% in the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 239,542 shares of the real estate investment trust's stock valued at $15,721,000 after purchasing an additional 189,096 shares during the period. 62.51% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

NHI has been the topic of several research analyst reports. Wells Fargo & Company dropped their target price on National Health Investors from $68.00 to $65.00 and set an "equal weight" rating on the stock in a research note on Monday. BMO Capital Markets reaffirmed an "outperform" rating on shares of National Health Investors in a research report on Wednesday, September 23rd. Huntington began coverage on National Health Investors in a research note on Monday, November 9th. They issued a "strong-buy" rating for the company. National Bank Financial set a $79.00 price target on National Health Investors in a report on Wednesday, September 9th. Finally, Zacks Research raised National Health Investors from a "strong sell" rating to a "hold" rating in a report on Tuesday, September 29th. One analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $79.11.

View Our Latest Analysis on NHI

National Health Investors Company Profile

(Get Free Report)

National Health Investors, Inc. NYSE: NHI is a real estate investment trust that owns and finances properties used for senior housing and health care. Founded in 1991, the company is headquartered in Murfreesboro, Tennessee. NHI's portfolio includes senior housing communities, such as independent living, assisted living and memory care properties, as well as skilled nursing facilities. It typically works with health care operators through property leases and mortgage loans. The company serves markets across the United States.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in National Health Investors Right Now?

Before you consider National Health Investors, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.

While National Health Investors currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines